Look for:

Our offer for

SINO BIOPHARMACEUTICAL LTD.


ISIN:
KYG8167W1380
WKN:
-

2024/04/23 10:32:16
Price
0.3056 EUR
Difference 8.75% (0.02)

General attributes

ISINKYG8167W1380
Symbol1177
ExchangeStuttgart
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)5,811 EUR
BenchmarkHANG SENG INDEX

Market data

Bid (Bid size)0.3056 EUR (6,200)
Ask (Ask size)0.318 EUR (6,200)
Open0.3056 EUR
High0.3056 EUR
Low0.3056 EUR
Close (prev. day)0.281 EUR
VWAP-
Volume (pcs)0
Trading volume0.00
Number of trades2
Last size0

Futures and Options

Related Futures-
Related Options-
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research

Date Headline Download
2024/04/03 en Global Equity Ratings PDF Download
2024/03/13 en Global Equity Ratings PDF Download
2024/02/22 en Global Equity Ratings PDF Download
2024/02/14 en Global Equity Ratings PDF Download
2024/01/23 en Global Equity Ratings PDF Download


2024/04/23 10:32:16
Price
0.3056 EUR
Difference 8.75% (0.02)

General attributes

ISINKYG8167W1380
Symbol1177
ExchangeStuttgart
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)5,811 EUR
BenchmarkHANG SENG INDEX

Market data

Bid (Bid size)0.3056 EUR (6,200)
Ask (Ask size)0.318 EUR (6,200)
Open0.3056 EUR
High0.3056 EUR
Low0.3056 EUR
Close (prev. day)0.281 EUR
VWAP-
Volume (pcs)0
Trading volume0.00
Number of trades2
Last size0

Performance and Risk

6m1Y3Y
Perf (%)-10.51%-44.75%-68.07%
Perf (abs.)-0.03-0.23-0.60
Beta1.362.971.13
Volatility58.8652.1849.89
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)0.2786 EUR (14,265)
Ø price 30 days | Ø volume 30 days (pcs.)0.3355 EUR (3,009)
Ø price 100 days | Ø volume 100 days (pcs.)0.3555 EUR (2,033)
Ø price 250 days | Ø volume 250 days (pcs.)0.3779 EUR (1,349)
YTD High | date0.3970 EUR (2024/01/03)
YTD Low | date0.2677 EUR (2024/04/18)
52 Weeks High | date0.5014 EUR (2023/04/24)
52 Weeks Low | date0.2677 EUR (2024/04/18)

All listings for SINO BIOPHARMACEUTICAL LTD.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Tradegate2024/04/2318:450.3183 EUR0.014
Stuttgart2024/04/2310:320.3056 EUR0.002
Munich2024/04/2308:020.3056 EUR0.001
Hong Kong Stock Exchange2024/04/2310:092.58 HKD--
Hanover2024/04/2308:000.3056 EUR0.001
Frankfurt2024/04/2308:020.3028 EUR0.001
FINRA other OTC Issues2024/04/1915:470.3150 USD0.001
Duesseldorf2024/04/2316:300.3046 EUR0.004
Berlin2024/04/2308:080.3042 EUR0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=142261&ID_TYPE_IMAGE_LOGO=2

Contact Details

SINO BIOPHARMACEUTICAL LTD.
- -
- - - -
Telefon: -
Fax: -
E-mail: -

Company Profile

-

Members of Management Board

Li YiChairman of Managing Board
Cheng Cheung LingMember of Executive Committee
Li MingqinMember of Executive Committee
Theresa TseMember of Executive Committee
Tian ZhoushanMember of Executive Committee
Tse HsinMember of Executive Committee
Tse PingMember of Executive Committee
Tse, EricMember of Executive Committee
Wang ShanchunMember of Executive Committee

Board of directors

Theresa TseChairman of Supervisory Board
Kwok Tung LiMember of Supervisory Board
Zheng Fei LuMember of Supervisory Board
Cheung Ling ChengMember of Supervisory Board
Da Kui LiMember of Supervisory Board
Hong LuMember of Supervisory Board
Hsin TseMember of Supervisory Board
Lu Fu ZhangMember of Supervisory Board
Ming Qin LiMember of Supervisory Board
Ping TseMember of Supervisory Board
Zhou Shan TianMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer